Akari Therapeutics Plc (AKTX)
5.12
+0.51
(+11.06%)
USD |
NASDAQ |
Apr 16, 16:00
4.86
-0.26
(-5.08%)
After-Hours: 20:00
Akari Therapeutics Cash from Investing (Quarterly) : 0.00 for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| DBV Technologies SA | -0.7165M |
| Cellectis SA | 22.57M |
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 0.00 |
| Bicycle Therapeutics Plc | -0.5731M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.039M |
| Cash from Financing (Quarterly) | 5.764M |
| Free Cash Flow | -10.59M |
| Free Cash Flow to Equity (Quarterly) | -1.676M |
| Free Cash Flow to Firm (Quarterly) | -2.305M |
| Free Cash Flow Yield | -21.48% |